Arcus Biosciences, Inc. (NYSE:RCUS) Receives $31.29 Average Target Price from Brokerages
Shares of Arcus Biosciences, Inc. (NYSE:RCUS – Get Free Report) have received a consensus recommendation of “Moderate Buy” ...
Noticing This Sign On Your Knuckles Can Reveal High Cholesterol
Another sign, called tendon xanthomata, leads to swelling in areas like your knuckles, the back of your ankle, and the ...
Yankees Showcase $37 Million Pitcher in Spring Training Amid Uncertain Future
Marcus Stroman got his 2025 Spring Training with the New York Yankees back on track. The controversial right-hander was at ...
Burnley thrash Sheffield Wednesday to close gap on automatic promotion places
Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...
Mongabay on MSN12h
DRC government directive triggers panic in ape sanctuaries amid ongoing conflict
For primate sanctuaries in the Democratic Republic of Congo, the year 2025 has begun with panic, worry and uncertainty as ...
Gilead price target raised to $120 from $105 at Bernstein
Bernstein raised the firm’s price target on Gilead (GILD) to $120 from $105 and keeps an Outperform rating on the shares. The firm notes Gilead ...
Grupo Aval Acciones y Valores (AVAL) Expected to Announce Quarterly Earnings on Monday
Grupo Aval Acciones y Valores (NYSE:AVAL – Get Free Report) is anticipated to issue its quarterly earnings data before the market opens on Monday, February 24th. Analysts expect the company to ...